Tag Archives: Drug Side Effects

Featured Stories

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Death in Those Taking Bactrim with ACE Inhibitors or ARBs

Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs

Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...
Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

FDA backs previous stance on Pradaxa bleeding risks

Federal health officials have issued an update on its stance on the new blood thinner drug Pradaxa, indicating the risk of severe bleeding associated with the drug is no more significant than any other drugs available on the market for … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , |

Bisphosphonate drugs Fosamax, Boniva not right for women in “pre-menopause”

Women suffering from osteopenia, often referred to as pre-menopause, should avoid taking bisphosphonate drugs like Fosamax to prevent bone loss in most circumstances. Consumer Reports magazine’s team of medical experts issued this advisory when questioned about the use of these … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged , |

Elderly Dementia Linked to Anxiety, Insomnia Drugs

Elderly patients taking benzodiazepines or other similar anxiety or insomnia drugs are more likely to develop symptoms of dementia than those who avoid the drugs entirely. According to a WebMD.com report on a new study appearing in the journal, British … Continue reading

Posted in Pharmaceuticals | Tagged |

Doctors Petition FDA to Act on Opioid Painkillers

In response to growing opioid pain prescribing practice abuse, a group of doctors has petitioned the U.S. Food & Drug Administration (FDA) to take action on the powerful and powerfully addictive painkillers. Opioids are highly potent drugs approved for moderate … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged |

Watchdog Says FDA Needs Drug Safety Tracking Database

A leading public health advocacy group has suggested the Food and Drug Administration (FDA) approve a comprehensive system for tracking adverse reactions and dangerous side effects of prescription drugs once they reach the U.S. market. According to a HealthDay News … Continue reading

Posted in Pharmaceuticals | Tagged |

Report Finds FDA Post-Market Oversight of Drugs is Improving

A just-released report finds that the U.S. Food & Drug Administration’s (FDA) oversight of drugs is improving, says the agency. The report states that the FDA has strengthened the way in which it monitors post-approval drug safety—approved drugs receive equal … Continue reading

Posted in Pharmaceuticals | Tagged |

U.K. Regulator Warns of Tolvaptan Side Effects

A U.K. regulator just issued a warning over side effects linked to Tolvaptan. Side effects include serious neurological events. Tolvaptan is a selective vasopressin V2-receptor antagonist used for the treatment of adults diagnosed with hyponatremia, secondary to inappropriate anti-diuretic hormone … Continue reading

Posted in Pharmaceuticals | Tagged |

Study Finds Doctors Frequently Prescribe Drugs Off-Label

A new study finds that doctors are frequently prescribing medications for off-label uses The study looked at the off-label prescribing practices of primary care physicians in a Canadian network, said Science Daily. The report was published in Online First by … Continue reading

Posted in Pharmaceuticals | Tagged |

Drug Marketing Campaigns Obscure Side Effects

Although drug makers must indicate a drug’s adverse effects on its labeling, drug marketing campaigns obscure drug side effects. OpEdNews notes that 100,000 Americans die every year over complications from prescribed drugs; another 1.5 million people become ill or seriously … Continue reading

Posted in Legal News | Tagged |

Plavix – Aspirin Combo Linked to Higher Risk of Gastrointestinal bleeding

Taking low doses of aspirin along with the blood thinning drug < "http://www.yourlawyer.com/topics/overview/Plavix-Cerebral-Gastrointestinal-Bleeding-Hemorrhaging-Lawsuit-Lawyer">Plavix could increase the risk of gastrointestinal bleeding, according to a new study. According to a Reuters report, the authors of the study calculated that if 1,000 people … Continue reading

Posted in Legal News | Tagged , , , , , |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.